[
    [
        {
            "time": "2018-05-14",
            "original_text": "Gilead Collaborates with Hookipa for HBV and HIV Therapies",
            "features": {
                "keywords": [
                    "Gilead",
                    "Hookipa",
                    "HBV",
                    "HIV",
                    "Therapies"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Gilead Collaborates with Hookipa for HBV and HIV Therapies",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive",
            "features": {
                "keywords": [
                    "Abbvie",
                    "ABBV",
                    "Upadacitinib",
                    "RA",
                    "Study",
                    "Data",
                    "Positive"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-06-03",
            "original_text": "ASCO Ends: Winners & Losers at the Key Cancer Research Event",
            "features": {
                "keywords": [
                    "ASCO",
                    "Winners",
                    "Losers",
                    "Cancer",
                    "Research"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "both"
            },
            "scores": {
                "News_content": "ASCO Ends: Winners & Losers at the Key Cancer Research Event",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive",
            "features": {
                "keywords": [
                    "Abbvie",
                    "ABBV",
                    "Upadacitinib",
                    "RA",
                    "Study",
                    "Data",
                    "Positive"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-03-10",
            "original_text": "2 Cheap Dividend Stocks You Can Buy Right Now",
            "features": {
                "keywords": [
                    "Cheap",
                    "Dividend",
                    "Stocks",
                    "Buy",
                    "Now"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "investing"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2 Cheap Dividend Stocks You Can Buy Right Now",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]